Tosco Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.23 Cr
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 10.87%
- Profit Growth -30.72%
- Ebitda -1.47%
- Net Worth 7.73%
- Total Assets 46.82%
About Tosco Pharmachem
Tosco Pharmachem Private Limited (TPPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 24 May 2019 (Five years and eight months 25 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Kanumuri and Atsushi Tsumori serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52500TG2019FTC132918
-
Company No.
132918
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
24 May 2019
-
Date of AGM
07 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Tosco Pharmachem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Kanumuri
|
Managing Director | 24-May-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atsushi Tsumori
|
Director | 24-May-2019 | Current |
Financial Performance of Tosco Pharmachem.
Tosco Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.87% increase. The company also saw a substantial fall in profitability, with a 30.72% decrease in profit. The company's net worth moved up by a moderate rise of 7.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tosco Pharmachem?
In 2022, Tosco Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gmfc Pharma Private LimitedSrinivasa Kanumuri is a mutual person
-
Gmfc Labs Private LimitedSrinivasa Kanumuri is a mutual person
-
Tosco Pharma Private LimitedSrinivasa Kanumuri is a mutual person
-
Db Luxure Private Limited
Srinivasa Kanumuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tosco Pharmachem?
Unlock and access historical data on people associated with Tosco Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tosco Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tosco Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.